共 5 条
- [5] A randomised comparison of paclitaxel (T) and carboplatin (J) versus a control arm of single agent carboplatin (J) or cyclophosphamide, doxorubicin and cisplatin (CAP): 2074 patients randomised into the 3rd International Collaborative Ovarian Neoplasm Study (ICON3). BRITISH JOURNAL OF CANCER, 1999, 80 : 14 - 14